SOURCE: Implant Sciences

Implant Sciences

August 26, 2010 10:57 ET

Implant Sciences Invited to Participate in Executive Trade Mission to India

Implant Executives to Meet With Key Decision Makers at Each of India's Security Agencies; Building Upon Prior Sales to India

WILMINGTON, MA--(Marketwire - August 26, 2010) -  Implant Sciences Corporation (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that it has been selected to join an executive trade mission to India beginning on September 6, 2010. Implant Sciences was one of a select few companies invited to participate, based on the Company's success in deploying its Quantum Sniffer ™ QS-H150 handheld explosive trace detectors in defense and law enforcement agencies throughout India.

The U.S.-India Business Council (USIBC), formed in 1975 at the request of the Government of India and the U.S. Government to advance commercial ties between the world's two largest free-market democracies and hosted under the aegis of the U.S. Chamber of Commerce in Washington, DC, is leading the trade mission in advance of President Obama's highly anticipated November visit to India. USIBC has previously led nine aerospace & defense executive missions to India since 2001 promoting a deeper defense and strategic partnership between both countries. During the mission, Implant Sciences expects to be introduced to leaders of India's homeland security and defense agencies, including the National Security Advisor, Foreign Secretary, Director General of the Indian Coast Guard, Director General of the Central Reserve Police Force, and others.

In the aftermath of the November 2008 attacks in Mumbai, the Government of India has embarked on an ambitious plan to modernize and upgrade its homeland security apparatus. The homeland security budget has been growing at an annual rate of 25% to fund the planned improvements in police and paramilitary forces, secure urban centers against terrorism and create a safe economic environment for the country as a whole. Now, more than ever, the Government of India is looking to U.S. companies for their expertise and high-end technology to provide solutions to some of India's most urgent problems.

Glenn Bolduc, CEO of Implant Sciences, commented, "We are extremely pleased to have been invited by the USIBC to participate in this important trade mission. India is the world's largest democracy and an important ally to the United States and Implant Sciences is proud of its contribution towards enhancing the security of India and its citizens. We look forward to the opportunity to build on our success in the country."

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc, CEO
    Email Contact

    Investor Contact:
    Laurel Moody
    Email Contact